FWRG Q2 Revenue Rises 15.2% but EBITDA Forecast Cut on Higher Costs

What happened

First Watch reported Q2 revenue growth of 15.2%, driven by positive same-restaurant sales and new openings, but lowered its full-year adjusted EBITDA guidance due to higher costs tied to strong demand. The revenue beat the low end of prior outlook, yet profitability fell short as commodity and labor inflation persisted, compressing margins. This reinforces the structural challenge of converting robust restaurant-level unit economics into thin consolidated operating margins, which remain near 3–4%. With net debt/EBITDA at 7.9x and interest coverage at just 1.48x, any margin disappointment amplifies financial risk. The results align with the bear case, where top-line momentum fails to translate into sustainable earnings growth at the corporate level.

Implication

The Q2 update highlights a core weakness: healthy restaurant-level margins are not flowing through to the bottom line because corporate costs, commodity inflation, and labor expenses continue to erode profitability. With 2026 EBITDA guidance now reduced, the long-anticipated margin recovery is pushed further out, and the company’s high leverage (7.9x net debt/EBITDA) leaves little cushion. At ~20x EV/EBITDA, the market is still pricing in rapid margin improvement that may not materialize in the near term. Even as demand stays robust, the guidance cut suggests cost pressures are structural rather than temporary. Given the heavy debt and capital-intensive growth strategy, downside risk is amplified, and investors should remain skeptical of the valuation until margins show sustainable improvement.

Thesis delta

The Q2 results strengthen the bear thesis: robust revenue growth is insufficient to drive EBITDA expansion due to persistent cost inflation. Management’s decision to lower full-year EBITDA guidance, even as it raised the low end of the sales outlook, confirms that margin recovery will remain elusive. No change to the view that FWRG’s risk–reward is unfavorable at current levels.